Kentaro Yamazaki

14.5k citations
278 papers · 3.7k indexed · 1 hit paper · h-index 30

Kentaro Yamazaki

256 papers receiving 3.7k citations

Hit Papers

Ramucirumab versus placebo in combination with second-lin...6522015202620182022200400600

Peers

Kentaro Yamazaki
Comparison fields: 5 of 111
  • Oncology 2.4k
  • Hepatology 461
  • Pulmonary and Respiratory Medicine 1.5k
  • Pathology and Forensic Medicine 629
  • Gastroenterology 184
Replace Woo Yong Lee with:
Woo Yong Lee South Korea
Filippo Pietrantonio Italy
Carlo Barone Italy
Côme Lepage France
Kanwal Raghav United States
David R. Fogelman United States
Gianluca Tomasello Italy
Sylvain Manfrédi France
Pia Österlund Finland
Jean‐François Seitz France
Kentaro Yamazaki relative to Woo Yong Lee South Korea Woo Yong Lee's profile →
Citations per field
00.5×1.5×
Woo Yong Lee · 1×
Citations per year

Countries citing papers authored by Kentaro Yamazaki

Since Specialization
Citations

This map shows the geographic impact of Kentaro Yamazaki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kentaro Yamazaki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kentaro Yamazaki more than expected).

Fields of papers citing papers by Kentaro Yamazaki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kentaro Yamazaki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kentaro Yamazaki. The network helps show where Kentaro Yamazaki may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Kentaro Yamazaki, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Kentaro Yamazaki Line = papers co-authored together Kentaro Yamazaki links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20250
2 20241
3 20242
4 20243
5 20235
6 20231
7 20231
8 20236
9 20221
10 20211
11 20212
12 20207
13 20208
14 20208
15 201832
16 20163
17 20150
18
Phase I study of sunitinib plus modified FOLFOX6 in Japanese patients with treatment-naive colorectal cancer.
20126
19 20083
20 2003121

About Kentaro Yamazaki

Kentaro Yamazaki is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Hepatology, having authored 278 papers that have together received 3.7k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (178 papers), Gastric Cancer Management and Outcomes (103 papers), Cancer Treatment and Pharmacology (82 papers), Lung Cancer Treatments and Mutations (58 papers), Genetic factors in colorectal cancer (33 papers), Cancer Genomics and Diagnostics (29 papers), Hepatocellular Carcinoma Treatment and Prognosis (24 papers) and Colorectal Cancer Surgical Treatments (16 papers). The work is most often cited by research in Oncology (2.4k citations), Hepatology (461 citations) and Pulmonary and Respiratory Medicine (1.5k citations). Kentaro Yamazaki has collaborated with scholars based in Japan, United States and Belgium. Frequent co-authors include Takayuki Yoshino, Atsushi Ohtsu, Narikazu Boku, Seiji Shiotani, Noriyoshi Ohashi, Eric Van Cutsem, Mototsugu Kohno, Tomohiro Nishina, Kei Muro and Rocio García‐Carbonero. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Gastroenterology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026